Management of intrathecal catheter-tip inflammatory masses: An updated 2007 consensus statement from an expert panel

Timothy Deer, Elliot S. Krames, Samuel Hassenbusch, Allen Burton, David Caraway, Stuart Dupen, James Eisenach, Michael Erdek, Eric Grigsby, Phillip Kim, Robert Levy, Gladstone McDowell, Nagy Mekhail, Sunil Panchal, Joshua Prager, Richard Rauck, Michael Saulino, Todd Sitzman, Peter Staats, Michael Stanton-HicksLisa Stearns, K. Dean Willis, William Witt, Kenneth Follett, Mark Huntoon, Leong Liem, James Rathmell, Mark Wallace, Eric Buchser, Michael Cousins, Ann Ver Donck

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Background. Expert panel of physicians and nonphysicians, all expert in intrathecal (IT) therapies, convened in the years 2000 and 2003 to make recommendations for the rational use of IT analgesics based on the preclinical and clinical literature known up to those times, presentations of the expert panel, discussions on current practice and standards, and the result of surveys of physicians using IT agents. An expert panel of physicians and convened in 2007 to review previous recommendations and to form recommendations for the rational use of IT agents as they pertain to new scientific and clinical information regarding the etiology, prevention and treatment for IT granuloma. Method. A review of preclinical and clinical literature from 2000 to 2006 was undertaken and disseminated to an expert panel of physicians. Focused discussions concerning the rational use of IT agents and its relationship to the etiology of, prevention of, and treatment of IT granuloma were held. Results. This report presents here new knowledge of the etiology of catheter tip granuloma and guidelines for its prevention and treatment.

Original languageEnglish (US)
Pages (from-to)77-91
Number of pages15
JournalNeuromodulation
Volume11
Issue number2
DOIs
StatePublished - Apr 1 2008

Fingerprint

Catheters
Granuloma
Physicians
Therapeutics
Analgesics
Guidelines

Keywords

  • Complications
  • Etiology
  • Granuloma formation
  • Intrathecal
  • Nonopioids
  • Opioids
  • Prevention
  • Treatment

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Deer, T., Krames, E. S., Hassenbusch, S., Burton, A., Caraway, D., Dupen, S., ... Ver Donck, A. (2008). Management of intrathecal catheter-tip inflammatory masses: An updated 2007 consensus statement from an expert panel. Neuromodulation, 11(2), 77-91. https://doi.org/10.1111/j.1525-1403.2008.00147.x

Management of intrathecal catheter-tip inflammatory masses : An updated 2007 consensus statement from an expert panel. / Deer, Timothy; Krames, Elliot S.; Hassenbusch, Samuel; Burton, Allen; Caraway, David; Dupen, Stuart; Eisenach, James; Erdek, Michael; Grigsby, Eric; Kim, Phillip; Levy, Robert; McDowell, Gladstone; Mekhail, Nagy; Panchal, Sunil; Prager, Joshua; Rauck, Richard; Saulino, Michael; Sitzman, Todd; Staats, Peter; Stanton-Hicks, Michael; Stearns, Lisa; Dean Willis, K.; Witt, William; Follett, Kenneth; Huntoon, Mark; Liem, Leong; Rathmell, James; Wallace, Mark; Buchser, Eric; Cousins, Michael; Ver Donck, Ann.

In: Neuromodulation, Vol. 11, No. 2, 01.04.2008, p. 77-91.

Research output: Contribution to journalArticle

Deer, T, Krames, ES, Hassenbusch, S, Burton, A, Caraway, D, Dupen, S, Eisenach, J, Erdek, M, Grigsby, E, Kim, P, Levy, R, McDowell, G, Mekhail, N, Panchal, S, Prager, J, Rauck, R, Saulino, M, Sitzman, T, Staats, P, Stanton-Hicks, M, Stearns, L, Dean Willis, K, Witt, W, Follett, K, Huntoon, M, Liem, L, Rathmell, J, Wallace, M, Buchser, E, Cousins, M & Ver Donck, A 2008, 'Management of intrathecal catheter-tip inflammatory masses: An updated 2007 consensus statement from an expert panel', Neuromodulation, vol. 11, no. 2, pp. 77-91. https://doi.org/10.1111/j.1525-1403.2008.00147.x
Deer, Timothy ; Krames, Elliot S. ; Hassenbusch, Samuel ; Burton, Allen ; Caraway, David ; Dupen, Stuart ; Eisenach, James ; Erdek, Michael ; Grigsby, Eric ; Kim, Phillip ; Levy, Robert ; McDowell, Gladstone ; Mekhail, Nagy ; Panchal, Sunil ; Prager, Joshua ; Rauck, Richard ; Saulino, Michael ; Sitzman, Todd ; Staats, Peter ; Stanton-Hicks, Michael ; Stearns, Lisa ; Dean Willis, K. ; Witt, William ; Follett, Kenneth ; Huntoon, Mark ; Liem, Leong ; Rathmell, James ; Wallace, Mark ; Buchser, Eric ; Cousins, Michael ; Ver Donck, Ann. / Management of intrathecal catheter-tip inflammatory masses : An updated 2007 consensus statement from an expert panel. In: Neuromodulation. 2008 ; Vol. 11, No. 2. pp. 77-91.
@article{0b1daf2be7c54de9bef2f05aef45b4b7,
title = "Management of intrathecal catheter-tip inflammatory masses: An updated 2007 consensus statement from an expert panel",
abstract = "Background. Expert panel of physicians and nonphysicians, all expert in intrathecal (IT) therapies, convened in the years 2000 and 2003 to make recommendations for the rational use of IT analgesics based on the preclinical and clinical literature known up to those times, presentations of the expert panel, discussions on current practice and standards, and the result of surveys of physicians using IT agents. An expert panel of physicians and convened in 2007 to review previous recommendations and to form recommendations for the rational use of IT agents as they pertain to new scientific and clinical information regarding the etiology, prevention and treatment for IT granuloma. Method. A review of preclinical and clinical literature from 2000 to 2006 was undertaken and disseminated to an expert panel of physicians. Focused discussions concerning the rational use of IT agents and its relationship to the etiology of, prevention of, and treatment of IT granuloma were held. Results. This report presents here new knowledge of the etiology of catheter tip granuloma and guidelines for its prevention and treatment.",
keywords = "Complications, Etiology, Granuloma formation, Intrathecal, Nonopioids, Opioids, Prevention, Treatment",
author = "Timothy Deer and Krames, {Elliot S.} and Samuel Hassenbusch and Allen Burton and David Caraway and Stuart Dupen and James Eisenach and Michael Erdek and Eric Grigsby and Phillip Kim and Robert Levy and Gladstone McDowell and Nagy Mekhail and Sunil Panchal and Joshua Prager and Richard Rauck and Michael Saulino and Todd Sitzman and Peter Staats and Michael Stanton-Hicks and Lisa Stearns and {Dean Willis}, K. and William Witt and Kenneth Follett and Mark Huntoon and Leong Liem and James Rathmell and Mark Wallace and Eric Buchser and Michael Cousins and {Ver Donck}, Ann",
year = "2008",
month = "4",
day = "1",
doi = "10.1111/j.1525-1403.2008.00147.x",
language = "English (US)",
volume = "11",
pages = "77--91",
journal = "Neuromodulation",
issn = "1094-7159",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Management of intrathecal catheter-tip inflammatory masses

T2 - An updated 2007 consensus statement from an expert panel

AU - Deer, Timothy

AU - Krames, Elliot S.

AU - Hassenbusch, Samuel

AU - Burton, Allen

AU - Caraway, David

AU - Dupen, Stuart

AU - Eisenach, James

AU - Erdek, Michael

AU - Grigsby, Eric

AU - Kim, Phillip

AU - Levy, Robert

AU - McDowell, Gladstone

AU - Mekhail, Nagy

AU - Panchal, Sunil

AU - Prager, Joshua

AU - Rauck, Richard

AU - Saulino, Michael

AU - Sitzman, Todd

AU - Staats, Peter

AU - Stanton-Hicks, Michael

AU - Stearns, Lisa

AU - Dean Willis, K.

AU - Witt, William

AU - Follett, Kenneth

AU - Huntoon, Mark

AU - Liem, Leong

AU - Rathmell, James

AU - Wallace, Mark

AU - Buchser, Eric

AU - Cousins, Michael

AU - Ver Donck, Ann

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Background. Expert panel of physicians and nonphysicians, all expert in intrathecal (IT) therapies, convened in the years 2000 and 2003 to make recommendations for the rational use of IT analgesics based on the preclinical and clinical literature known up to those times, presentations of the expert panel, discussions on current practice and standards, and the result of surveys of physicians using IT agents. An expert panel of physicians and convened in 2007 to review previous recommendations and to form recommendations for the rational use of IT agents as they pertain to new scientific and clinical information regarding the etiology, prevention and treatment for IT granuloma. Method. A review of preclinical and clinical literature from 2000 to 2006 was undertaken and disseminated to an expert panel of physicians. Focused discussions concerning the rational use of IT agents and its relationship to the etiology of, prevention of, and treatment of IT granuloma were held. Results. This report presents here new knowledge of the etiology of catheter tip granuloma and guidelines for its prevention and treatment.

AB - Background. Expert panel of physicians and nonphysicians, all expert in intrathecal (IT) therapies, convened in the years 2000 and 2003 to make recommendations for the rational use of IT analgesics based on the preclinical and clinical literature known up to those times, presentations of the expert panel, discussions on current practice and standards, and the result of surveys of physicians using IT agents. An expert panel of physicians and convened in 2007 to review previous recommendations and to form recommendations for the rational use of IT agents as they pertain to new scientific and clinical information regarding the etiology, prevention and treatment for IT granuloma. Method. A review of preclinical and clinical literature from 2000 to 2006 was undertaken and disseminated to an expert panel of physicians. Focused discussions concerning the rational use of IT agents and its relationship to the etiology of, prevention of, and treatment of IT granuloma were held. Results. This report presents here new knowledge of the etiology of catheter tip granuloma and guidelines for its prevention and treatment.

KW - Complications

KW - Etiology

KW - Granuloma formation

KW - Intrathecal

KW - Nonopioids

KW - Opioids

KW - Prevention

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=41749114058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41749114058&partnerID=8YFLogxK

U2 - 10.1111/j.1525-1403.2008.00147.x

DO - 10.1111/j.1525-1403.2008.00147.x

M3 - Article

C2 - 22151039

AN - SCOPUS:41749114058

VL - 11

SP - 77

EP - 91

JO - Neuromodulation

JF - Neuromodulation

SN - 1094-7159

IS - 2

ER -